X0609 4 2026-09-08 0001635088 Roivant Sciences Ltd. ROIV 0001349297 Fitzgerald Meghan true C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 X0 SW1H 0DB UNITED KINGDOM true true Common Shares 2026-09-08 4 M 0 20000 8.8 A 62963 D Common Shares 2026-09-08 4 S 0 20000 39.9 D 42963 D Stock Option (Right to Buy) 8.8 2026-09-08 4 M 0 20000 0 D 2033-04-19 Common Stock 20000 18578 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.90 to $40.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 30, 2026. Reflects an award of stock options to purchase Common Shares that is fully vested. Exhibit 24 - Power of Attorney By: /s/ Sam Kaplan, as Attorney-in-Fact for Meghan FitzGerald 2026-09-10